New diabetes drug faces off against standard treatment in 200-Patient trial
NCT ID NCT07122102
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 29 times
Summary
This study tests a new medicine called cofrogliptin against an older one, acarbose, in 200 adults with type 2 diabetes who have never taken diabetes drugs. The goal is to see which works better at lowering blood sugar and has fewer side effects. Participants will take one of the two pills for several weeks, and doctors will track changes in blood sugar levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
He'nan Provincial People's Hospital
Zhengzhou, Henan, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.